Aprea TherapeuticsAPRE
13F holders, Q3 2025 (September 30)23holders
2new positions
2sold out
$1.48avg. 13F price*
At the end of Q3 2025, 23 institutions reported holding Aprea Therapeutics Inc. (APRE) in their 13F filings, unchanged from Q2 2025. 2 opened new positions and 2 sold out. The largest holders were AIGH Capital Management LLC ($795K), Sphera Funds Management LTD. ($398K) and Nantahala Capital Management, LLC ($303K).
- Company
- Aprea Therapeutics Inc.
- CUSIP
- 03836J201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $18K |
| Exits | 2 | $25K |
All 13F filers, Q2 2025 → Q3 2025: 17,932 shares bought and 214,589 shares sold, net −196,657 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| AIGH Capital Management LLC | 0.28% | No change | 539,300 | $795K |
| Sphera Funds Management LTD. | 0.09% | No change | 270,000 | $398K |
| Nantahala Capital Management, LLC | 0.02% | No change | 205,760 | $303K |
| Vanguard Group Inc. | 0.00% | Reduce -9.0% | 158,238 | $233K |
| DAFNA Capital Management LLC | 0.05% | No change | 137,174 | $202K |
| Sio Capital Management, LLC | 0.04% | Reduce -59.8% | 112,223 | $166K |
| Morgan Stanley | 0.00% | Add +3.9% | 65,808 | $97K |
| Geode Capital Management, LLC | 0.00% | Add +3.4% | 44,616 | $66K |
| BNP Paribas Financial Markets | 0.00% | Add +11.0% | 17,132 | $25K |
| LPL Financial LLC | 0.00% | Reduce -5.9% | 16,052 | $24K |
| HighTower Advisors, LLC | 0.00% | No change | 13,864 | $20K |
| HRT Financial LP | 0.00% | New | 12,264 | $18K |
| Landscape Capital Management, L.L.C. | 0.00% | Reduce -56.2% | 10,496 | $15K |
| BlackRock, Inc. | 0.00% | No change | 8,504 | $13K |
| Bank of America Corp. | 0.00% | Add +0.1% | 4,861 | $7K |
| Mb, Levis & Associates, LLC | 0.00% | No change | 806 | $1K |
| Group One Trading LLC | 0.00% | No change | 577 | $851 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -80.8% | 568 | $838 |
| Osaic Holdings, Inc. | 0.00% | No change | 400 | $609 |
| WealthCollab, LLC | 0.00% | No change | 158 | $234 |
| SBI Securities Co., Ltd. | 0.00% | Add +5.0% | 42 | $62 |
| Citigroup Inc. | 0.00% | New | 5 | $7 |
| UBS Group AG | 0.00% | Reduce -62.5% | 3 | $4 |
"% of holder's portfolio" is APRE's weight in each manager's 13F, not the share of Aprea Therapeutics Inc. the manager owns.